{
  "docId": "019de514-084e-749f-aab3-c526821d6723",
  "docSlug": "4e6a3f2f850bb694ad767fcc07848dcb",
  "documentTitle": "Bluejay | Investor Presentation Deck | 20 slides",
  "authorId": "bluejay",
  "authorName": "Bluejay Diagnostics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 20,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 16,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de514-084e-749f-aab3-c526821d6723/10",
  "deckHref": "/decks/019de514-084e-749f-aab3-c526821d6723",
  "deckJsonHref": "/decks/019de514-084e-749f-aab3-c526821d6723.json",
  "deckAnchorHref": "/decks/019de514-084e-749f-aab3-c526821d6723#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.018,
        "w": 0.79,
        "x": 0.038,
        "y": 0.118
      },
      "kind": "paragraph",
      "text": "Uses well-accepted ELISA² chemistry plus unique microfluidics/nanotechnology platform",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7651ced3-b5bb-45d4-b0a7-12c3d249a6f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.51,
        "x": 0.035,
        "y": 0.83
      },
      "kind": "source-note",
      "text": "1. Source: Bluejay Diagnostics market research\n2. ELISA = Enzyme-Linked Immunosorbent Assay\n3, Bluejay/Industry information, pending the location of the testing lab\n4. EUA = Emergency Use Authorization for management of Covid-19 patients",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "346f3305-947d-45f2-a84c-2a5393a0dc68",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.602,
        "w": 0.93,
        "x": 0.035,
        "y": 0.192
      },
      "kind": "table",
      "text": "Potential Advantages: Near Patient, Test System Size, Sample type, Sample Pre-process, Time from test to result, Requires Dedicated Personnel (phlebotomist/MedTech), System/Infrastructure Cost, FDA EUA for IL-64. Bluejay's Symphony System: Near patient, Desk Top, Whole blood, No, ~20 minutes, No, $, Yes. Beckman Coulter: Central Lab, Very Large, Serum/plasma, Yes, 4-48hr3, Yes, $$$, Yes. Siemens: Central Lab, Very Large, Serum/plasma, Yes, 4-48hr3, Yes, $$$, Yes. Roche: Central Lab, Very Large, Serum/plasma, Yes, 4-48hr3, Yes, $$$, Yes.",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78d88b2a-20e4-4521-b4f9-103d154676d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.729,
        "x": 0.035,
        "y": 0.075
      },
      "kind": "title",
      "text": "Symphony System Potential Advantages¹ v. Other Selected Tests",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45200d53-0a07-4467-9a88-62f61d427a48",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "ebac08c4-6711-467f-99ce-a7a3cb38fe65",
      "evidence": "The components include a table/data point list.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}